Skip to content
10-Q

Quarterly Report

PROTO SCRIPT PHARMACEUTICAL CORP

0001640334-18-000110

← back to feed
Filed
Jan 17, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2017 · Jan 9, 2018 49.14M sh
Capex Q2 2017 · Jun 30, 2017 $21.02K
Stockholders Equity Q2 2017 · Jun 30, 2017 −$1.16M
Stockholders Equity Q2 2017 · Dec 31, 2016 −$319.74K
Current Liabilities Q2 2017 · Jun 30, 2017 $1.32M
Current Liabilities Q2 2017 · Dec 31, 2016 $489.93K
Current Assets Q2 2017 · Jun 30, 2017 $116.48K
Current Assets Q2 2017 · Dec 31, 2016 $144.65K
Total Assets Q2 2017 · Jun 30, 2017 $166.28K
Total Assets Q2 2017 · Dec 31, 2016 $170.19K
Sga Expense Q2 2017 · Jun 30, 2017 $274.27K
Sga Expense Q2 2017 · Jun 30, 2017 $643.34K
Sga Expense Q2 2017 · Jun 30, 2016 $142.68K
Sga Expense Q2 2017 · Jun 30, 2016 $308.09K
Net Income Q2 2017 · Jun 30, 2017 −$332.57K
Net Income Q2 2017 · Jun 30, 2017 −$838.44K
Net Income Q2 2017 · Dec 31, 2016 $7.18M
Net Income Q2 2017 · Jun 30, 2016 −$67.75K
Net Income Q2 2017 · Jun 30, 2016 $81.34K
Operating Income Q2 2017 · Jun 30, 2017 −$244.19K
Operating Income Q2 2017 · Jun 30, 2017 −$505.93K
Operating Income Q2 2017 · Jun 30, 2016 −$67.75K
Operating Income Q2 2017 · Jun 30, 2016 $81.34K
Gross Profit Q2 2017 · Jun 30, 2017 $30.08K
Gross Profit Q2 2017 · Jun 30, 2017 $137.42K
Gross Profit Q2 2017 · Jun 30, 2016 $74.93K
Gross Profit Q2 2017 · Jun 30, 2016 $389.42K
Cost Of Revenue Q2 2017 · Jun 30, 2017 $84.3K
Cost Of Revenue Q2 2017 · Jun 30, 2017 $115.24K
Cost Of Revenue Q2 2017 · Jun 30, 2016 $56.64K
Cost Of Revenue Q2 2017 · Jun 30, 2016 $85.36K
Cash And Equivalents Q2 2017 · Dec 31, 2016 $3.51K
Cash And Equivalents Q2 2017 · Jun 30, 2016 $16.53K
Cash And Equivalents Q2 2017 · Dec 31, 2015 $9.09K
Dividends Paid Q2 2017 · Jun 30, 2016 $59.59K